{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:49:50Z","timestamp":1776318590338,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10787-026-02170-0","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T12:33:31Z","timestamp":1772454811000},"page":"2361-2374","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative efficacy of transdermal buprenorphine versus diclofenac in the management of knee osteoarthritis: a randomized controlled trial with network pharmacology insights"],"prefix":"10.1007","volume":"34","author":[{"given":"Abhay","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sneha","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil Kumar","family":"Gulia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivani","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prem Shankar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soniya","family":"Rani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"issue":"1","key":"2170_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.26502\/josm.511500192","volume":"7","author":"A Aabedi","year":"2025","unstructured":"Aabedi A, Fraix MP, Agrawal DK (2025) Surgical interventions in severe osteoarthritis: pros and cons. J Orthop Sports Med 7(1):169\u2013178","journal-title":"J Orthop Sports Med"},{"issue":"10","key":"2170_CR2","volume":"14","author":"A Awachat","year":"2022","unstructured":"Awachat A, Shukla D, Bhola ND (2022) Efficacy of diclofenac transdermal patch in therapeutic extractions: a literature review. Cureus 14(10):e30411","journal-title":"Cureus"},{"issue":"2","key":"2170_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s40744-020-00196-6","volume":"7","author":"F Bariguian Revel","year":"2020","unstructured":"Bariguian Revel F, Fayet M, Hagen M (2020) Topical diclofenac, an efficacious treatment for osteoarthritis: a narrative review. Rheumatol Ther 7(2):217\u2013236","journal-title":"Rheumatol Ther"},{"issue":"2","key":"2170_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101564","volume":"34","author":"S Bierma-Zeinstra","year":"2020","unstructured":"Bierma-Zeinstra S et al (2020) Nonpharmacological and nonsurgical approaches in OA. Best Pract Res Clin Rheumatol 34(2):101564","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2170_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2023.110925","volume":"130","author":"MT Bjelkar\u00f8y","year":"2024","unstructured":"Bjelkar\u00f8y MT et al (2024) Measuring pain intensity in older adults. Can the visual analogue scale and the numeric rating scale be used interchangeably? Prog Neuropsychopharmacol Biol Psychiatry 130:p. 110925","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"2170_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/bja\/aen103","volume":"101","author":"H Breivik","year":"2008","unstructured":"Breivik H et al (2008) Assessment of pain. Br J Anaesth 101(1):17\u201324","journal-title":"Br J Anaesth"},{"issue":"3","key":"2170_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.sjpain.2010.05.035","volume":"1","author":"H Breivik","year":"2010","unstructured":"Breivik H et al (2010) A 6 months, randomised, placebo-controlled evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine transdermal patch in osteoarthritis patients na\u00efve to potent opioids. Scand J Pain 1(3):122\u2013141","journal-title":"Scand J Pain"},{"issue":"5","key":"2170_CR8","doi-asserted-by":"publisher","first-page":"R105","DOI":"10.1186\/ar2308","volume":"9","author":"L Bursell","year":"2007","unstructured":"Bursell L et al (2007) Src kinase inhibition promotes the chondrocyte phenotype. Arthritis Res Ther 9(5):R105","journal-title":"Arthritis Res Ther"},{"key":"2170_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103476","volume":"73","author":"S Chakraborty","year":"2022","unstructured":"Chakraborty S et al (2022) Current progressions in transdermal drug delivery systems for management of rheumatoid and osteoarthritis: a comprehensive review. J Drug Deliv Sci Technol 73:103476","journal-title":"J Drug Deliv Sci Technol"},{"key":"2170_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b1732","volume":"338","author":"P Charles","year":"2009","unstructured":"Charles P et al (2009) Reporting of sample size calculation in randomised controlled trials: review. BMJ 338:b1732","journal-title":"BMJ"},{"issue":"7","key":"2170_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cells8070734","volume":"8","author":"M-C Choi","year":"2019","unstructured":"Choi M-C et al (2019) NF-\u03baB signaling pathways in osteoarthritic cartilage destruction. Cells 8(7):734","journal-title":"Cells"},{"key":"2170_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11206013","author":"S Coaccioli","year":"2022","unstructured":"Coaccioli S et al (2022) Osteoarthritis: New insight on its pathophysiology. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11206013","journal-title":"J Clin Med"},{"issue":"8","key":"2170_CR13","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.joca.2011.03.011","volume":"19","author":"PG Conaghan","year":"2011","unstructured":"Conaghan PG et al (2011) Transdermal buprenorphine plus oral paracetamol vs an oral codeine-paracetamol combination for osteoarthritis of hip and\/or knee: a randomised trial. Osteoarthritis Cartilage 19(8):930\u2013938","journal-title":"Osteoarthritis Cartilage"},{"issue":"6","key":"2170_CR14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3899\/jrheum.210543","volume":"49","author":"PG Conaghan","year":"2022","unstructured":"Conaghan PG et al (2022) WOMAC meaningful within-patient change: results from 3 studies of Tanezumab in patients with moderate-to-severe osteoarthritis of the hip or knee. J Rheumatol 49(6):615","journal-title":"J Rheumatol"},{"issue":"Suppl 3","key":"2170_CR15","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/ar4174","volume":"15","author":"L Crofford","year":"2013","unstructured":"Crofford L (2013) Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther 15(Suppl 3):S2","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"2170_CR16","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.jval.2024.06.017","volume":"27","author":"N Dardenne","year":"2024","unstructured":"Dardenne N, Donneau A-F, Bruy\u00e8re O (2024) Mapping the Lequesne functional index into the EQ-5D-5L Utility Index in patients with knee osteoarthritis. Value Health 27(10):1400\u20131407","journal-title":"Value Health"},{"issue":"11","key":"2170_CR17","first-page":"2271","volume":"33","author":"CF Dillon","year":"2006","unstructured":"Dillon CF et al (2006) Prevalence of knee osteoarthritis in the United States: arthritis data from the third national health and nutrition examination survey 1991\u201394. J Rheumatol 33(11):2271\u20132279","journal-title":"J Rheumatol"},{"issue":"3","key":"2170_CR18","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3390\/pr13030907","volume":"13","author":"K Drosopoulou","year":"2025","unstructured":"Drosopoulou K et al (2025) Topical and transdermal delivery of nonsteroidal anti-inflammatory drugs (NSAIDs) for inflammation and pain: current trends and future directions in delivery systems. Processes 13(3):907","journal-title":"Processes"},{"issue":"1","key":"2170_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1517\/17425247.2013.736961","volume":"10","author":"PS Gupta","year":"2013","unstructured":"Gupta PS, Sharma V, Pathak K (2013) Melt sonocrystallized piroxicam for oral delivery: particle characterization, solid state analysis, and pharmacokinetics. Expert Opin Drug Deliv 10(1):17\u201332","journal-title":"Expert Opin Drug Deliv"},{"key":"2170_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/JPR.S6503","volume":"2","author":"G Hans","year":"2009","unstructured":"Hans G, Robert D (2009) Transdermal buprenorphine - a critical appraisal of its role in pain management. J Pain Res 2:117\u2013134","journal-title":"J Pain Res"},{"issue":"10182","key":"2170_CR21","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","volume":"393","author":"DJ Hunter","year":"2019","unstructured":"Hunter DJ, Bierma-Zeinstra S (2019) Osteoarthritis. Lancet 393(10182):1745\u20131759","journal-title":"Lancet"},{"issue":"3","key":"2170_CR22","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jpainsymman.2004.07.005","volume":"29","author":"RE Johnson","year":"2005","unstructured":"Johnson RE, Fudala PJ, Payne R (2005) Buprenorphine: considerations for pain management. J Pain Symptom Manage 29(3):297\u2013326","journal-title":"J Pain Symptom Manage"},{"issue":"11","key":"2170_CR23","volume":"16","author":"S Kandasamy","year":"2024","unstructured":"Kandasamy S et al (2024) Exploring the burden of knee osteoarthritis in rural South India: community prevalence, risk factors, and functional assessment among adults aged 40 and above. Cureus 16(11):e73452","journal-title":"Cureus"},{"issue":"1","key":"2170_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jpainsymman.2012.06.014","volume":"46","author":"RP Kapil","year":"2013","unstructured":"Kapil RP et al (2013) Once-weekly transdermal buprenorphine application results in sustained and consistent steady-state plasma levels. J Pain Symptom Manage 46(1):65\u201375","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"2170_CR25","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.clinthera.2009.03.001","volume":"31","author":"M Karlsson","year":"2009","unstructured":"Karlsson M, Berggren AC (2009) Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg\/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study. Clin Ther 31(3):503\u2013513","journal-title":"Clin Ther"},{"issue":"4","key":"2170_CR26","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1185\/03007995.2013.873714","volume":"30","author":"J Karlsson","year":"2014","unstructured":"Karlsson J et al (2014) Is buprenorphine transdermal patch equally safe and effective in younger and elderly patients with osteoarthritis-related pain? Results of an age-group controlled study. Curr Med Res Opin 30(4):575\u2013587","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"2170_CR27","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3390\/molecules23030681","volume":"23","author":"W Leppert","year":"2018","unstructured":"Leppert W, Malec-Milewska M, Zajaczkowska R, Wordliczek J (2018) Transdermal and topical drug administration in the treatment of pain. Molecules 23(3):681","journal-title":"Molecules"},{"issue":"4","key":"2170_CR28","first-page":"779","volume":"24","author":"MG Lequesne","year":"1997","unstructured":"Lequesne MG (1997) The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 24(4):779\u2013781","journal-title":"J Rheumatol"},{"issue":"2","key":"2170_CR29","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s40122-021-00260-1","volume":"10","author":"A Magni","year":"2021","unstructured":"Magni A et al (2021) Management of osteoarthritis: expert opinion on NSAIDs. Pain Ther 10(2):783\u2013808","journal-title":"Pain Ther"},{"issue":"1","key":"2170_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0340974","volume":"21","author":"SM Matalqah","year":"2026","unstructured":"Matalqah SM et al (2026) Bio-waste derived fluorescent carbon dots based biodegradable mechanically strong hydrogel for stimuli-responsive nonsteroidal anti-inflammatory drug (NSAID) delivery. PLoS ONE 21(1):e0340974","journal-title":"PLoS ONE"},{"issue":"1","key":"2170_CR31","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10067-014-2701-4","volume":"35","author":"R Mu","year":"2016","unstructured":"Mu R et al (2016) Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with knee osteoarthritis: a randomized controlled non-inferiority trial. Clin Rheumatol 35(1):165\u2013173","journal-title":"Clin Rheumatol"},{"issue":"5","key":"2170_CR32","doi-asserted-by":"publisher","first-page":"518","DOI":"10.4103\/0019-5413.189608","volume":"50","author":"CP Pal","year":"2016","unstructured":"Pal CP et al (2016) Epidemiology of knee osteoarthritis in India and related factors. Indian J Orthop 50(5):518\u2013522","journal-title":"Indian J Orthop"},{"key":"2170_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2023.1253460","volume":"4","author":"FF Pandelani","year":"2023","unstructured":"Pandelani FF et al (2023) Chronic pain: its impact on the quality of life and gender. Front Pain Res Lausanne 4:1253460","journal-title":"Front Pain Res Lausanne"},{"key":"2170_CR34","doi-asserted-by":"publisher","first-page":"1454601","DOI":"10.3389\/fphar.2024.1454601","volume":"15","author":"A Papa","year":"2024","unstructured":"Papa A et al (2024) Long-term efficacy and reduced side-effects of buprenorphine in patients with moderate and severe chronic pain. Front Pharmacol 15:1454601","journal-title":"Front Pharmacol"},{"issue":"9","key":"2170_CR35","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1039\/D4TB02012J","volume":"13","author":"D Pareek","year":"2025","unstructured":"Pareek D et al (2025) Mesoporous polymeric nanoparticles for effective treatment of inflammatory diseases: an in vivo study. J Mater Chem B 13(9):3094\u20133113","journal-title":"J Mater Chem B"},{"issue":"18","key":"2170_CR36","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.2165\/11208250-000000000-00000","volume":"71","author":"GL Plosker","year":"2011","unstructured":"Plosker GL (2011) Buprenorphine 5, 10 and 20 \u03bcg\/h transdermal patch. Drugs 71(18):2491\u20132509","journal-title":"Drugs"},{"key":"2170_CR37","doi-asserted-by":"publisher","DOI":"10.4103\/joasis.joasis_6_23","author":"R Prabhoo","year":"2023","unstructured":"Prabhoo R et al (2023) Expert consensus on S-Etodolac in the management of osteoarthritis from an Indian perspective. J Orthop Assoc South Indian States. https:\/\/doi.org\/10.4103\/joasis.joasis_6_23","journal-title":"J Orthop Assoc South Indian States"},{"issue":"4","key":"2170_CR38","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.joca.2022.11.005","volume":"31","author":"MJ Richard","year":"2023","unstructured":"Richard MJ, Driban JB, McAlindon TE (2023) Pharmaceutical treatment of osteoarthritis. Osteoarthritis Cartilage 31(4):458\u2013466","journal-title":"Osteoarthritis Cartilage"},{"issue":"9","key":"2170_CR39","doi-asserted-by":"publisher","first-page":"e508","DOI":"10.1016\/S2665-9913(23)00163-7","volume":"5","author":"JD Steinmetz","year":"2023","unstructured":"Steinmetz JD, Culbreth GT, Haile LM, Rafferty Q, Lo J, Fukutaki KG, Cruz JA, Smith AE, Vollset SE, Brooks PM, Cross M (2023) Global, regional, and national burden of osteoarthritis, 1990\u20132020 and projections to 2050: a systematic analysis for the global burden of disease study 2021. Lancet Rheumatol 5(9):e508\u2013e522","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"2170_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-025-00594-6","volume":"11","author":"S Tang","year":"2025","unstructured":"Tang S et al (2025) Osteoarthritis. Nat Rev Dis Primers 11(1):10","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"2170_CR41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.46497\/ArchRheumatol.2022.8863","volume":"37","author":"M Tuncay Duru\u00f6z","year":"2022","unstructured":"Tuncay Duru\u00f6z M et al (2022) Validity and reliability of the mini-osteoarthritis knee and hip quality of life scale in Turkish population. Arch Rheumatol 37(1):119\u2013128","journal-title":"Arch Rheumatol"},{"key":"2170_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2026.116205","volume":"172","author":"W-c Yan","year":"2026","unstructured":"Yan W-c et al (2026) Tissue-specific dysregulation of S100A8 in synovium and cartilage reveals limitations of NSAID therapy in inflammatory arthritis. Int Immunopharmacol 172:116205","journal-title":"Int Immunopharmacol"},{"key":"2170_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.109904","volume":"260","author":"D Yang","year":"2024","unstructured":"Yang D et al (2024) Revisiting prostaglandin E2: a promising therapeutic target for osteoarthritis. Clin Immunol 260:109904","journal-title":"Clin Immunol"},{"key":"2170_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56110614","author":"MHM Yunus","year":"2020","unstructured":"Yunus MHM, Nordin A, Kamal H (2020) Pathophysiological perspective of osteoarthritis. Medicina. https:\/\/doi.org\/10.3390\/medicina56110614","journal-title":"Medicina"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02170-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-026-02170-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-026-02170-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T05:07:51Z","timestamp":1776316071000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-026-02170-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2170"],"URL":"https:\/\/doi.org\/10.1007\/s10787-026-02170-0","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}